Works matching DE "ADEFOVIR dipivoxil"

Results: 91

Adefovir dipivoxil loaded proliposomal powders with improved hepatoprotective activity: formulation, optimization, pharmacokinetic, and biodistribution studies.

Published in:

Journal of Liposome Research, 2018, v. 28, n. 4, p. 259, doi. 10.1080/08982104.2017.1363228

By:

Abdelbary, Ghada A.;
Amin, Maha M.;
Zakaria, Mohamed Y.;
El Awdan, Sally A.

Publication type:

Article

Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.

Published in:

Oncology Letters, 2017, v. 13, n. 1, p. 307, doi. 10.3892/ol.2016.5393

By:

YONG LIN;
FAN PAN;
YINGCHAO WANG;
ZIQIAN CHEN;
CHUN LIN;
LVFENG YAO;
XIN ZHANG;
RUI ZHOU;
CHEN PAN

Publication type:

Article

Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.

Published in:

Journal of Gastroenterology, 2014, v. 49, n. 6, p. 1094, doi. 10.1007/s00535-013-0864-4

By:

Suzuki, Fumitaka;
Hosaka, Tetsuya;
Suzuki, Yoshiyuki;
Akuta, Norio;
Sezaki, Hitomi;
Hara, Tasuku;
Kawamura, Yusuke;
Kobayashi, Masahiro;
Saitoh, Satoshi;
Arase, Yasuji;
Ikeda, Kenji;
Kobayashi, Mariko;
Watahiki, Sachiyo;
Mineta, Rie;
Kumada, Hiromitsu

Publication type:

Article

Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B.

Published in:

Journal of Gastroenterology, 2014, v. 49, n. 3, p. 470, doi. 10.1007/s00535-013-0779-0

By:

Tanaka, Mio;
Suzuki, Fumitaka;
Seko, Yuya;
Hara, Tasuku;
Kawamura, Yusuke;
Sezaki, Hitomi;
Hosaka, Tetsuya;
Akuta, Norio;
Kobayashi, Masahiro;
Suzuki, Yoshiyuki;
Saitoh, Satoshi;
Arase, Yasuji;
Ikeda, Kenji;
Kobayashi, Mariko;
Kumada, Hiromitsu

Publication type:

Article

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 6897, doi. 10.2147/OTT.S120062

By:

Jian-Hong Zhong;
Yang Ke;
Shao-Liang Zhu;
Lin Wang;
Cheng-Piao Luo;
Wen-Feng Gong;
Xue-Mei You;
Liang Ma;
Bang-De Xiang;
Le-Qun Li

Publication type:

Article

Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(t)ide analogues.

Published in:

Indian Journal of Medical Research, 2013, v. 137, n. 6, p. 1208

By:

Goel, Varun;
Bose, Purabi Deka;
Sarma, Manash P.;
Hazam, Rajib K.;
Das, Bhudev C.;
Gondal, Ranjana;
Kar, Premashis

Publication type:

Article

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1282, doi. 10.1111/apt.15020

By:

Udompap, Prowpanga;
Kim, Donghee;
Ahmed, Aijaz;
Kim, W. Ray

Publication type:

Article

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 6, p. 730, doi. 10.1111/apt.14497

By:

Wong, G. L.‐H.;
Wong, V. W.‐S.;
Chan, H. L.‐Y.;
Seto, W.‐K.;
Yuen, M.‐F.

Publication type:

Article

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 1, p. 114, doi. 10.1111/apt.14362

By:

Wong, D.;
Littlejohn, M.;
Yuen, L.;
Jackson, K.;
Mason, H.;
Bayliss, J.;
Rosenberg, G.;
Gaggar, A.;
Kitrinos, K.;
Subramanian, M.;
Marcellin, P.;
Buti, M.;
Janssen, H. L. A.;
Gane, E.;
Locarnini, S.;
Thompson, A.;
Revill, P. A.

Publication type:

Article

Front & Back Matter.

Published in:: Intervirology, 2014, v. 57, n. 5, p. X, doi. 10.1159/000357634
Publication type:: Article

Adefovir and Lamivudine Combination Therapy in Patients with Entecavir-Resistant Chronic Hepatitis B: Antiviral Responses and Evolution of Mutations.

Published in:

Intervirology, 2014, v. 57, n. 5, p. 239, doi. 10.1159/000360399

By:

Yim, Hyung Joon;
Lee, Hyun Jung;
Suh, Sang Jun;
Seo, Yeon Seok;
Kim, Chang Wook;
Lee, Chang Don;
Park, Sang Hoon;
Lee, Myung Seok;
Park, Choong Kee;
Chae, Hee Bok;
Kim, Moon Young;
Baik, Soon Koo;
Kim, Yun Soo;
Kim, Ju Hyun;
Lee, Jung Il;
Lee, Jin Woo;
Hong, Sun Pyo;
Um, Soon Ho

Publication type:

Article

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance.

Published in:

Intervirology, 2013, v. 57, n. 1, p. 8, doi. 10.1159/000353851

By:

Seo, Seung Young;
Kim, In Hee;
Sohn, Ji Youn;
Lee, Seok;
Kim, Seong Hun;
Kim, Sang Wook;
Lee, Seung Ok;
Lee, Soo Teik;
Kim, Dae-Ghon

Publication type:

Article

Deep Sequencing Analysis of HBV Genotype Shift and Correlation with Antiviral Efficiency during Adefovir Dipivoxil Therapy.

Published in:

PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0131337

By:

Wang, Yuwei;
Shan, Xuefeng;
Liang, Zhi;
Shan, Youlan;
Huang, Wenxiang;
Zhang, Dazhi;
Zen, Aizhong;
Zhou, Xin;
Zhao, Yao;
Gong, Xuyang;
Xu, Ge;
Zhang, Xiuyu;
Chen, Juan;
Huang, Ailong

Publication type:

Article

Differential Binding of Tenofovir and Adefovir to Reverse Transcriptase of Hepatitis B Virus.

Published in:

PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106324

By:

van Hemert, Formijn J.;
Berkhout, Ben;
Zaaijer, Hans L.

Publication type:

Article

rtM204Q May Serve as a Novel Lamivudine-Resistance-Associated Mutation of Hepatitis B Virus.

Published in:

PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089015

By:

Liu, Yan;
Xu, Zhihui;
Wang, Yan;
Li, Xiaodong;
Liu, Liming;
Chen, Li;
Xin, Shaojie;
Xu, Dongping

Publication type:

Article

Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.

Published in:

Clinical & Experimental Medicine, 2016, v. 16, n. 3, p. 429, doi. 10.1007/s10238-015-0373-2

By:

Cai, Shaohang;
Yu, Tao;
Jiang, Yegui;
Zhang, Yonghong;
Lv, Fangfang;
Peng, Jie

Publication type:

Article

Kushenin combined with adefovir dipivoxil affects the HBV-DNA load in serum, immune functions and liver functions of patients with chronic hepatitis B.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 14, n. 6, p. 5837, doi. 10.3892/etm.2017.5266

By:

JING FENG;
JIANDONG HUANG;
ZHIQIN LI

Publication type:

Article

Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 12, n. 4, p. 2511, doi. 10.3892/etm.2016.3623

By:

LITING TIAN;
QILIN FU;
FU HUANG

Publication type:

Article

Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 11, n. 6, p. 2293, doi. 10.3892/etm.2016.3230

By:

YANG WANG;
SHUANG LIU;
YU CHEN;
SUJUN ZHENG;
LI ZHOU;
FENGMIN LU;
ZHONGPING DUAN

Publication type:

Article

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 11, n. 1, p. 117, doi. 10.3892/etm.2015.2855

By:

YANG WANG;
SHUANG LIU;
YU CHEN;
SUJUN ZHENG;
LI ZHOU;
TSEN HUA;
SHAOFEI SUI;
FENGMIN LU;
ZHONGPING DUAN

Publication type:

Article

Cimicifuga foetida L. plus adefovir effectively inhibits the replication of hepatitis B virus in patients with chronic hepatitis B.

Published in:

Biomedical Reports, 2016, v. 4, n. 4, p. 493, doi. 10.3892/br.2016.601

By:

XIUFANG DAI;
XIANFU YI;
ZEQUN SUN;
PENG RUAN

Publication type:

Article

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 98, doi. 10.1111/apt.12344

By:

Singal, A. K.;
Salameh, H.;
Kuo, Y.‐F.;
Fontana, R. J.

Publication type:

Article

Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 7, p. 710, doi. 10.1111/apt.12251

By:

Hartono, J. L.;
Aung, M. O.;
Dan, Y. Y.;
Gowans, M.;
Lim, K.;
Lee, Y. M.;
Lee, G. H.;
Low, H. C.;
Tan, P. S.;
Thwin, M. A.;
Soon, C.;
Chiu, L. ‐ L.;
Khoo, M. J.;
Koay, E.;
Lim, S. G.

Publication type:

Article

Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.

Published in:

Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 12, p. 1482, doi. 10.1111/j.1365-2036.2012.05105.x

By:

Hadziyannis, S. J.

Publication type:

Article

Single-drug treatments for chronic hepatitis B: summarising current information by network meta-analysis.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 1, p. 105, doi. 10.1111/j.1365-2036.2011.04689.x

By:

Messori, A.;
Del Santo, F.;
Maratea, D.;
Trippoli, S.

Publication type:

Article

Elevation in Serum Concentration of Bone-Specific Alkaline Phosphatase without Elevation in Serum Creatinine Concentration Secondary to Adefovir Dipivoxil Therapy in Chronic Hepatitis B Virus Infection.

Published in:

Hepatitis Research & Treatment, 2013, p. 1, doi. 10.1155/2013/739247

By:

Hiroshi Abe;
Nobuyoshi Seki;
Tomonori Sugita;
Yuta Aida;
Haruya Ishiguro;
Tamihiro Miyazaki;
Munenori Itagaki;
Satoshi Sutoh;
Yoshio Aizawa

Publication type:

Article

Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.

Published in:

Virology Journal, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12985-015-0323-3

By:

Jiahong Yang;
Gao Chen;
Xuebing Chen;
Hao Zhang;
Di Jiang;
Guang Yang

Publication type:

Article

Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis.

Published in:

Renal Failure, 2014, v. 36, n. 9, p. 1404, doi. 10.3109/0886022X.2014.952745

By:

Li, Hui;
Yuan, Xinke;
Qiu, Linlin;
Zhou, Qiaoling;
Xiao, Ping

Publication type:

Article

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients.

Published in:

Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 4, p. 748, doi. 10.1111/jgh.12835

By:

Liang, Xieer;
Cheng, Jun;
Sun, Yongtao;
Chen, Xinyue;
Li, Tong;
Wang, Hao;
Jiang, Jianning;
Chen, Xiaoping;
Long, Hui;
Tang, Hong;
Yu, Yanyan;
Sheng, Jifang;
Chen, Shijun;
Niu, Junqi;
Ren, Hong;
Shi, Junping;
Dou, Xiaoguang;
Wan, Mobin;
Jiang, Jiaji;
Xie, Qing

Publication type:

Article

Safety and efficacy of entecavir in adefovir-experienced patients.

Published in:

Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 1, p. 43, doi. 10.1111/jgh.12728

By:

Nguyen, Nghia H;
Trinh, Huy N;
Nguyen, Thuan T;
Do, Son T;
Tran, Phuong;
Nguyen, Huy A;
Nguyen, Khanh K;
Garcia, Ruel T;
Lutchman, Glen A;
Nguyen, Mindie H

Publication type:

Article

Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.

Published in:

Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 7, p. 1485, doi. 10.1111/jgh.12567

By:

Heo, Jeong;
Ahn, Sang Hoon;
Kweon, Young‐Oh;
Kim, Byung‐Ho;
Chan, Henry L Y;
Horban, Andrzej;
Wongcharatrawee, Suchat;
Llamoso, Cyril;
Lee, Kwan Sik

Publication type:

Article

In this issue.

Published in:: Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 9, p. iii, doi. 10.1111/j.1440-1746.2012.info413.x
Publication type:: Article

Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance.

Published in:

Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 9, p. 1454, doi. 10.1111/j.1440-1746.2011.07050.x

By:

Kim, Yu Jin;
Paik, Seung Woon;
Sinn, Dong Hyun;
Gwak, Geum-Youn;
Choi, Moon Seok;
Lee, Joon Hyeok;
Koh, Kwang Cheol;
Yoo, Byung Chul

Publication type:

Article

Prevention and management of drug resistant hepatitis B virus infections.

Published in:

Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 9, p. 1432, doi. 10.1111/j.1440-1746.2012.07198.x

By:

Wang, Cheng;
Fan, Rong;
Sun, Jian;
Hou, Jinlin

Publication type:

Article

rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.

Published in:

Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 2, p. 300, doi. 10.1111/j.1440-1746.2011.06853.x

By:

Lee, Yoon-Seon;
Chung, Young-Hwa;
Kim, Jeong A;
Jin, Young Joo;
Park, Won Hyung;
Kim, Sung Eun;
Lee, Danbi;
Shim, Ju Hyun;
Kim, Kang Mo;
Lim, Young Suk;
Lee, Han Chu;
Lee, Yung Sang;
Suh, Dong Jin

Publication type:

Article

Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients.

Published in:

Journal of Gastroenterology & Hepatology, 2012, v. 27, n. 2, p. 306, doi. 10.1111/j.1440-1746.2011.06852.x

By:

Kim, Yu Jin;
Cho, Hyun Chin;
Sinn, Dong Hyun;
Gwak, Geum-Youn;
Choi, Moon Seok;
Koh, Kwang Cheol;
Paik, Seung Woon;
Yoo, Byung Chul;
Lee, Joon Hyeok

Publication type:

Article

Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B.

Published in:

Digestion, 2013, v. 87, n. 3, p. 196, doi. 10.1159/000348853

By:

Chon, Young Eun;
Park, Jun Yong;
ahn, Sang Hoon;
Kim, Do Young;
Han, Kwang-Hyub;
Chon, Chae Yoon;
Choi, ara;
Kim, Seung Up

Publication type:

Article

Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.

Published in:

PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190581

By:

Lee, Heon Ju;
Kim, Sang Jin;
Kweon, Young Oh;
Park, Soo Young;
Heo, Jeong;
Woo, Hyun Young;
Hwang, Jae Seok;
Chung, Woo Jin;
Lee, Chang Hyeong;
Kim, Byung Seok;
Suh, Jeong Ill;
Tak, Won Young;
Jang, Byoung Kuk

Publication type:

Article

Development and Validation of a Sensitive LC-MS-MS Method for the Determination of Adefovir in Human Serum and Urine: Application to a Clinical Pharmacokinetic Study.

Published in:

Journal of Chromatographic Science, 2016, v. 54, n. 4, p. 507, doi. 10.1093/chromsci/bmv172

By:

Ye Zhang;
Lu Shen;
Ying Zhan;
Qing-Qing Xiao;
Jin Yang

Publication type:

Article

Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.

Published in:

Journal of Digestive Diseases, 2013, v. 14, n. 8, p. 446, doi. 10.1111/1751-2980.12065

By:

Cao, Zhen Huan;
Ma, Li Na;
Zhang, Hong Wei;
Liu, Ya Li;
Chen, Xin Yue

Publication type:

Article

LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV.

Published in:

Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 2, p. 175, doi. 10.1016/s1665-2681(19)30779-3

By:

Hongyu Jia;
Feng Ding;
Jianyang Chen;
Yimin Zhang;
Dairong Xiang;
Jiangshan Lian;
Linyan Zeng;
Liang Yu;
Jianhua Hu;
Yongtao Li;
Yingfeng Lu;
Yuanchun Liu;
Lin Zheng;
Lanjuan Li;
Yida Yang

Publication type:

Article

The Efficacy of Adefovir Plus Entecavir Combination Therapy in Patients with Chronic Hepatitis B Refractory to Both Lamivudine and Adefovir.

Published in:

Digestive Diseases & Sciences, 2013, v. 58, n. 5, p. 1363, doi. 10.1007/s10620-012-2480-1

By:

Cho, Yuri;
Lee, Dong;
Chung, Kwang;
Jin, Eunhyo;
Lee, Jeong-Hoon;
Cho, Eun;
Yu, Su;
Kim, Jin;
Jeong, Sook;
Yoon, Jung-Hwan;
Lee, Hyo-Suk;
Kim, Chung;
Kim, Yoon

Publication type:

Article

Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B.

Published in:

Digestive Diseases & Sciences, 2012, v. 57, n. 5, p. 1358, doi. 10.1007/s10620-011-1988-0

By:

Jeon, Jung;
Shin, Hyun;
Lee, Joung;
Joo, Kwang;
Cha, Jae;
Park, Jae;
Lim, Jun;
Lim, Kyuseong;
Kim, Sunyong

Publication type:

Article

Antiviral Drug Resistance Testing in Patients with Chronic Hepatitis B.

Published in:

Digestive Diseases & Sciences, 2012, v. 57, n. 1, p. 221, doi. 10.1007/s10620-011-1816-6

By:

Wong, Vincent;
Wong, Grace;
Tse, Chi-Hang;
Yuen, Lilly;
Chan, Hoi-Yun;
Locarnini, Stephen;
Chan, Henry

Publication type:

Article

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg‐positive chronic hepatitis B.

Published in:

Liver International, 2018, v. 38, n. 10, p. 1760, doi. 10.1111/liv.13716

By:

Wong, Darren;
Littlejohn, Margaret;
Edwards, Rosalind;
Jackson, Kathy;
Revill, Peter;
Gaggar, Anuj;
Kitrinos, Kathryn;
Subramanian, Mani;
Marcellin, Patrick;
Buti‐Ferret, Maria;
Janssen, Harry;
Gane, Ed;
Locarnini, Stephen;
Thompson, Alexander

Publication type:

Article

Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.

Published in:

Liver International, 2015, v. 35, n. 11, p. 2370, doi. 10.1111/liv.12845

By:

Chon, Young E.;
Jin, Bora;
Ahn, Sang H.;
Kim, Seungtaek;
Kim, Nam D.;
Park, Jeon H.;
Nam, Chung M.;
Kim, Kyun ‐ Hwan;
Hong, Sun P.;
Choi, Sung H.;
Kim, Do Y.;
Park, Jun Y.;
Han, Kwang ‐ Hyub

Publication type:

Article

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Published in:

Liver International, 2015, v. 35, n. 10, p. 2265, doi. 10.1111/liv.12831

By:

Baran, Bulent;
Soyer, Ozlem Mutluay;
Ormeci, Asli Cifcibasi;
Gokturk, Suut;
Evirgen, Sami;
Akyuz, Filiz;
Karaca, Cetin;
Demir, Kadir;
Besisik, Fatih;
Onel, Derya;
Gulluoglu, Mine;
Badur, Selim;
Kaymakoglu, Sabahattin

Publication type:

Article

Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA.

Published in:

Liver International, 2015, v. 35, n. 6, p. 1692, doi. 10.1111/liv.12753

By:

Lu, Junfeng;
Zhang, Shibin;
Liu, Yali;
Du, Xiaofei;
Ren, Shan;
Zhang, Hua;
Ma, Lina;
Chen, Yue;
Chen, Xinyue;
Shen, Chengli

Publication type:

Article

Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.

Published in:

Liver International, 2015, v. 35, n. 3, p. 805, doi. 10.1111/liv.12530

By:

Yoon, Seung Kew;
Seo, Yong Bok;
Im, Se Jin;
Bae, Si Hyun;
Song, Myeong Jun;
You, Chan Ran;
Jang, Jung Won;
Yang, Se Hwan;
Suh, You Suk;
Song, Ji Soo;
Kim, Byong Moon;
Kim, Chae Young;
Jeong, Sook Hyang;
Sung, Young Chul

Publication type:

Article

HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.

Published in:

Liver International, 2014, v. 34, n. 7, p. 1025, doi. 10.1111/liv.12343

By:

Liu, Yang;
Miller, Michael D.;
Kitrinos, Kathryn M.

Publication type:

Article